Glimibrit 2mg Tablet
strip of 15.0 tablets.Prescription required
About this product:
| Salt Composition: | Glimepiride (2mg) |
| Manufacturer: | Elbrit Life Sciences |
| Storage: | Below 25 degree celcius |
Out of Stock
Have doubts about this medicine?
Have doubts about this medicine?
Glimibrit 2mg Tablet is a sulfonylurea medication used to treat type 2 diabetes mellitus in adults, helping to control blood sugar levels and prevent complications. Glimibrit 2mg Tablet is an antidiabetic medication used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes thereby preventing serious complications of diabetes such as kidney damage and blindness.
Glimibrit 2mg Tablet is an antidiabetic medication. It works by increasing the amount of insulin released by the pancreas in order to lower blood glucose.
What is the recommended dosage of Glimibrit 2mg Tablet?
The starting dose of Glimibrit 2mg Tablet is typically 1 mg or 2 mg once daily, taken with breakfast. If you're at higher risk for low blood sugar (e.g., elderly or patients with renal impairment), the starting dose may be 1 mg once daily. The usual maintenance dose is 1–4 mg once daily, and the maximum recommended dose is 8 mg once daily.
Does Glimibrit 2mg Tablet cause sleepiness?
Glimibrit 2mg Tablet itself does not cause sleepiness. However, it may cause hypoglycemia (low blood sugar) when used with other anti-diabetes medication, which can lead to drowsiness or difficulty sleeping.
Is Glimibrit 2mg Tablet safe for kidneys?
Glimibrit 2mg Tablet does not affect the kidneys in patients with normal kidney function. However, its use should be avoided in patients with severe kidney disease since it is primarily eliminated by the kidneys.
Does Glimibrit 2mg Tablet cause memory loss?
No, it is not known that Glimibrit 2mg Tablet causes memory loss. However, the use of Glimibrit 2mg Tablet may cause low blood sugar, which can lead to symptoms such as dizziness, anxiety, irritability, and confusion.
Can people with diabetes eat proteins?
Yes, people with diabetes should include proteins along with other essential nutrients in their daily diet. Proteins are one of the major energy providers among all essential nutrients and can help regulate blood sugar levels when consumed in moderation.
Are artificial sweeteners good for people with diabetes?
No, artificial sweeteners are not good for people with diabetes. They are composed of chemicals that can cause mild to severe side effects and may worsen blood sugar control.
Can diabetes cause kidney failure?
Yes, uncontrolled diabetes can lead to diabetic nephropathy, which is a major cause of kidney failure in patients with diabetes. Keeping diabetes under control through lifestyle changes, diet, and medications can help prevent damage to the kidneys.
Can diabetes be cured?
While diabetes cannot be 'cured' in the classical sense, it can be effectively managed through simple lifestyle changes, diet, and medications. With proper management, people with diabetes can lead healthy lives and minimize the risk of complications.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Glimibrit 2mg Tablet is to be taken with food.
- Take Glimibrit 2mg Tablet shortly before or with the first main meal of the day (usually breakfast)
- Exercise regularly
- Eat a healthy diet and take your other diabetes medicines (if prescribed) alongside
- Monitor your blood sugar level regularly while you are taking Glimibrit 2mg Tablet
- Be careful while driving or operating machinery until you know how Glimibrit 2mg Tablet affects you
Alcohol
It is unsafe to consume alcohol with Glimibrit 2mg Tablet.
Breastfeed
Glimibrit 2mg Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Pregnancy
Glimibrit 2mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby.
